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Abstract		The	propensity	to	misfold	and	self-assemble	into	stable	aggregates	is	increasingly	recognised	as	a	 common	 feature	of	protein	molecules.	Our	understanding	of	 this	phenomenon	and	of	its	links	with	human	disease	has	increased	substantially	over	the	 last	 two	 decades.	 Studies	 thus	 far,	 however,	 have	 been	 almost	 exclusively	focussed	on	cytosolic	proteins,	resulting	in	a	lack	of	detailed	information	about	the	misfolding	 and	 aggregation	 of	 membrane	 proteins.	 As	 a	 consequence,	 although	such	proteins	make	up	approximately	30%	of	the	human	proteome	and	have	high	propensities	to	aggregate,	relatively	little	is	known	about	the	biophysical	nature	of	their	assemblies.	To	shed	light	on	this	issue,	we	have	studied	as	a	model	system	an	archetypical	 representative	 of	 the	 ubiquitous	 major	 facilitator	 superfamily,	 the	
Escherichia	 coli	 lactose	 permease	 (LacY).	 By	 using	 a	 combination	 of	 established	indicators	of	cross-β	 structure	and	morphology,	 including	 the	amyloid	diagnostic	dye	 thioflavin-T,	 circular	 dichroism,	 Fourier	 transform	 infrared	 spectroscopy,	 X-ray	fibre	diffraction,	and	transmission	electron	microscopy,	we	show	that	LacY	can	form	amyloid-like	fibrils	under	destabilising	conditions.	These	results	indicate	that	transmembrane	α-helical	proteins,	as	well	as	cytosolic	proteins,	have	the	ability	to	adopt	this	generic	state.														
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Introduction		A	wide	range	of	medical	conditions,	including	neurodegenerative	disorders	such	as	Alzheimer’s	 and	 Parkinson’s	 diseases,	 are	 associated	 with	 the	 misfolding	 and	aggregation	of	specific	proteins	into	amyloid	fibrils(1-4).	In	vivo	and	in	vitro	studies	of	 these	 disease-related	 aggregates	 have	 led	 to	 the	 recognition	 of	 their	 common	structural	 features,	 despite	 the	diversity	 of	 the	 amino	acid	 sequences	 and	native	state	 structures	 of	 the	 proteins	 by	which	 they	 are	 formed(4).	 In	 particular,	 it	 has	been	 shown	 that	 amyloid	 fibrils	 possess	 a	 cross-β	 architecture,	 in	 which	 the	 β-strands	 that	 make	 up	 the	 β-sheets	 are	 orientated	 perpendicularly	 to	 the	 fibril	axis(2,	4,	5).	As	this	fibrillar	architecture	can	be	adopted	by	a	wide	variety	of	different	proteins(6-9),	it	has	been	suggested	that	polypeptide	chains	have	a	generic	ability	to	form	amyloid	fibrils(4,	10).		Despite	 increasing	 evidence	 for	 the	 widespread	 nature	 of	 the	 amyloid	phenomenon(3,	4,	6),	 little	evidence	has	been	obtained	about	 this	 type	of	behaviour	in	 the	 case	 of	 membrane	 proteins.	 This	 absence	 of	 information	 is	 particularly	remarkable,	as	 it	 is	well	known	that	the	highly	hydrophobic	nature	of	membrane	proteins	 makes	 them	 prone	 to	 self-association	 and	 aggregation	 under	 many	conditions(11).	 Indeed,	 hundreds	 of	 membrane	 proteins	 have	 been	 observed	 to	aggregate	upon	ageing	 in	C.	elegans(12)	 and	a	 set	 of	 genes	 found	 to	be	associated	with	 human	 neurodegenerative	 disorders	 has	 been	 linked	 with	 membrane	proteins	 involved	 in	 the	 oxidative	 phosphorylation	 pathway(13).	 In	 addition,	predictive	models	of	protein	homeostasis	indicate	that	the	aggregation	propensity	of	 membrane	 proteins	 is	 disproportionately	 high(14).	 Moreover,	 the	 amyloid-β	peptide	(Aβ)	associated	with	Alzheimer’s	disease,	 is	a	proteolytic	fragment	of	the	membrane	 protein	 APP(15),	 and	 the	 aggregation	 and	 formation	 of	 fibrils	 by	fragments	of	luminal	membrane	protein	domains	has	been	reported(16).		Several	reasons	lie	behind	the	current	lack	of	detailed	structural	information	about	membrane	 protein	 aggregation,	 in	 particular	 the	 challenges	 inherent	 in	 their	recombinant	 production	 and	 purification.	 These	 steps	 remain	 among	 the	 major	
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bottlenecks	 in	 many	 structural	 and	 functional	 analyses	 of	 these	 important	biological	 components(17).	 In	 contrast	 to	 the	 situation	 of	 cytosolic	 proteins,	membrane	 proteins	 often	 require	 expression	 and	 purification	 procedures	 to	 be	carried	out	in	lipid	or	detergent	environments(18).	Despite	these	difficulties,	a	more	detailed	 knowledge	 of	 this	 group	 of	 proteins	 is	 absolutely	 essential	 for	 the	understanding	 of	 normal	 and	 aberrant	 biological	 processes,	 as	 they	 represent	about	30%	of	the	human	proteome(19)	and	comprise	the	vast	majority	of	currently	known	drug	targets(20).		Moreover,	 increased	 β-sheet	 structure	 has	 sparsely	 been	 reported	 for	 disease	related	membrane	proteins.	Perhaps	the	best	studied	of	these	proteins	is	the	cystic	fibrosis	 transmembrane	 conductance	 regulator	 (CFTR),	 an	 ABC	 transporter	containing	12	transmembrane	helices.	Several	mutations	of	this	membrane	protein	result	 in	a	variety	of	 cystic	 fibrosis	phenotypes(21),	 spanning	defects	 in	 synthesis,	processing,	trafficking,	as	well	as	functional	deficits.	Although	most	studies	report	a	 fast	 degradation	of	 dysfunctional	 CFTR	 rather	 than	 formation	of	 deposits(22),	 it	has	 been	 indicated	 that	misfolded	 aggregates	with	 highly	 organized	 arrays	 of	 β-strands	 can	 form	 for	 the	 P205	 mutant(23).	 Retinitis	 pigmentosa,	 a	 progressive	retinal	degenerative	disease,	has	been	 shown	 to	be	associated	with	mutations	 in	rhodopsin,	 an	 α-helical	 membrane	 protein	 of	 the	 G-coupled	 protein	 receptor	(GCPR)	 family(24).	 Indeed,	 since	 the	 majority	 of	 these	 mutations	 result	 in	 the	incorrect	folding	of	the	apoprotein	opsin,	retinitis	pigmentosa	has	been	classified	as	 a	 protein	 misfolding	 disease(25,	26).	 Despite	 the	 fact	 that	 misfolded	 opsin	 was	initially	 presumed	 to	 form	 disordered	 aggregates	 in	 the	 endoplasmic	 reticulum	(ER)(27),	 it	 has	 recently	 been	 shown	 that	 aggregates	 of	 the	 opsin	 variants	G188R	and	P23H,	formed	in	HEK293	cells,	exhibit	a	high	content	of	β-structure(28).	These	appear	 to	 be	 distinct	 from	 amyloid	 fibrils	 since	 they	 do	 not	 enhance	 the	fluorescence	of	ThT(28).	An	 increased	tendency	to	 form	ordered	β-sheet	structure	has	 also	 been	 reported	 for	 a	 model	 peptide	 with	 the	 partial	 sequence	 of	 a	transmembrane	domain	of	peripheral	myelin	protein	22	(PMP22)(29).	PMP22	is	an	α-helical	 transmembrane	 glycoprotein	 that	 is	 primarily	 expressed	 in	 Schwann	cells,	 and	 its	 mutations	 are	 known	 to	 cause	 the	 peripheral	 neuropathy	 Charcot	
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Marie-Tooth	 disease(30).	 Aggresome	 formation	 by	 this	 protein	 has	 been	 reported	upon	its	overexpression	in	mice,	although	the	structure	of	the	protein	within	these	aggregate-rich	 inclusions	 is	not	yet	 clear(31).	 In	addition,	 there	 is	 recent	evidence	for	 the	 formation	 of	 ThT-positive	 aggregates	 of	 the	 β-barrel	 transmembrane	domain	of	the	outer	membrane	protein	A	(OmpA)	formed	in	the	absence	of	lipid	or	lipid-mimetic	membranes	and	in	the	presence	of	high	concentrations	of	urea(32).			Overall,	although	increases	in	β-sheet	structure	have	been	reported	in	a	number	of	cases(23,	28,	31,	32),	it	still	remains	unclear	whether	membrane	proteins,	like	cytosolic	proteins,	have	an	 inherent	propensity	 to	 convert	 into	amyloid	 fibrils.	To	address	this	 problem,	 we	 have	 studied	 LacY,	 a	 representative	 of	 the	 major	 facilitator	superfamily	of	transporters	that	are	prevalent	across	prokaryotes	and	eukaryotes.	The	417-residue	protein	is	composed	of	12	transmembrane	α-helices	arranged	in	two	domains,	with	a	 substrate	binding	site	at	 the	domain	 interface(33).	 Its	 crystal	structure	has	been	solved	to	3.6	Å	resolution(34)	and	its	function	has	been	studied	in	great	detail(35).	The	structure	and	in	vitro	folding	of	LacY	have	been	studied	both	within	micelles	and	liposomes(36-38).	These	simple	lipid-mimetic	systems	represent	an	 ideal	 starting	 point	 for	 biophysical	 studies,	 and	 the	 relevance	 of	 their	 use	 is	supported	 by	 extensive	 studies	 showing	 the	 tolerance	 of	membrane	 proteins	 to	changing	lipid	environments(39).		We	should	mention	that,	in	vivo,	LacY	is	translated	directly	into	lipid	membranes	in	
E.	coli,	 in	the	same	way	that	most	membrane	proteins	are	directly	translated	into	the	ER	membrane	where	 they	 then	reside(40).	Furthermore,	a	network	of	quality-control	 mechanisms	 has	 co-evolved	 with	 the	 biosynthesis	 and	 trafficking	 of	membrane	 proteins	 in	 the	 ER,	 with	 the	 specific	 purpose	 to	 avoid	 their	aggregation.(41)	By	contrast,	in	our	in	vitro	study,	we	observe	aggregation	reactions	in	a	convenient	detergent	system.	Although	these	conditions	are	non-physiological,	and	our	 in	vitro	 assays	also	 lack	 the	protein	homeostasis	 controls	present	 in	 the	cellular	 environment,	 they	 enable	 us	 to	 explore	 the	 range	 of	 structural	 states	accessible	 to	 LacY.	 Consistently,	 a	 number	 of	 experimental	 studies	 have	 already	provided	 evidence	 of	 membrane	 protein	 aggregation	 within	 the	 cellular	
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environment.	For	example,	even	if	in	many	proteomics	studies	membrane	proteins	tend	 to	 be	 discarded	 prior	 to	 analysis(42),	 several	 studies	 have	 reported	 the	presence	 of	 membrane	 proteins	 in	 aggregates	 found	 in	 disease	 tissues.	 In	particular,	 lysosomal	 ATPase	 and	 mitochondrial	 ATPase	 components	 have	 been	found	 to	 co-aggregate	 in	 post-mortem	 amyloid	 plaques(43)	 and	 neurofibrillary	tangles(44),	 respectively,	 and	 the	 accumulation	 of	 the	 Parkin-associated	transmembrane	 receptor	 Pael-R	 in	 Lewy	 bodies	 has	 been	 reported(45).	 These	examples	 indicate	 that	 membrane	 proteins	 under	 stress	 can	 accumulate	 in	 vivo	outside	their	native	environments.		We	 report	 here	 the	 conversion	 of	 LacY	 into	 fibrillar	 aggregates	 with	 the	characteristic	features	of	the	cross-β	structure,	and	therefore	demonstrate	that	an	α-helical	 membrane	 protein	 can	 adopt	 a	 stable	 amyloid-like	 state	 analogous	 to	those	reported	for	cytosolic	proteins.			
Materials	and	Methods		
Generation	of	the	aggregation	propensity	profile	of	LacY	The	 CamSol	 method(46)	 was	 used	 to	 calculate	 the	 sequence-dependent	 intrinsic	solubility	of	LacY,	which	we	adopted	as	an	indicator	of	its	aggregation	propensity,	as	both	solubility	and	aggregation	propensity	describe	the	tendency	of	proteins	to	convert	 from	 the	 native	 state	 to	 insoluble	 aggregates.	 The	 CamSol	 method	 was	derived	 by	 considering	 the	 physico-chemical	 properties	 of	 the	 amino	 acid	sequences	that	are	most	responsible	for	their	aggregation	behaviour,	including	in	particular	the	hydrophobic	patterns,	which	tend	to	drive	the	aggregation	process,	and	the	presence	of	 ‘gatekeeper’	residues	(charged	residues	and	prolines),	which	tend	to	prevent	it(46).	The	indication	of	α-helices	and	coil	in	the	figure	was	based	on	the	native	structure	of	LacY(34,	47).		
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LacY	Expression	and	Purification	LacY	 was	 purified	 as	 previously	 described(37)	 with	 modifications.	 LacY	 was	expressed	 in	 One	 Shot	 BL21-AI	 chemically	 competent	 E.	 coli	 (Thermo	 Fisher	Scientific,	 Paisley,	 UK),	 using	 the	 kanamycin	 resistant	 plasmid	 pET-28a.	 The	cultures	were	grown	at	37	°C	in	LB	media	and	induced	with	0.1%	arabinose	and	1	mM	 IPTG	 at	 an	 OD600	 of	 0.7–0.8	 AU,	 and	 the	 cells	 were	 harvested	 by	centrifugation	(5000	X	g,	45	min).	Following	growth	and	induction,	the	cells	were	lysed	by	 three	 cycles	 in	 a	 high	pressure	homogenizer,	 and	 the	membranes	were	sedimented	 by	 centrifugation	 (100,000	 X	 g,	 4	 °C,	 30	 min)	 (Beck-man	 Coulter	Ultracentrifuge,	 rotor	 70Ti,	 High	 Wycombe,	 UK).	 The	 pellets	 were	 resuspended	and	 incubated	 (4	 °C,	 2	 h)	 in	 25	ml	 solubilisation	 buffer	 [200	mM	 NaCl,	 20	mM	imidazole,	 10	mM	 β-mercaptoethanol,	 40	mM	DDM	 and	 an	 EDTA	 free	 pro-tease	inhibitor	cocktail	tablet	(Roche	Diagnostics	Ltd,	Burgess	Hill,	UK)].	The	solubilised	membranes	were	centrifuged	(100,000	X	g,	4	°C,	30	min),	and	the	supernatans	was	retained	for	purification.	For	all	steps	of	purification,	the	buffer	contained	50	mM	sodium	phosphate	(pH	7.4),	10%	(v/v)	glycerol,	10	mM	β-mercaptoethanol	and	1	mM	 DDM,	 with	 additional	 components	 indicated	 in	 brackets.	 Initial	 purification	was	per-formed	with	a	1	mL	HisTrap	HP	Ni2+-affinity	column	(GE	Healthcare	Ltd,	Little	 Chalfont,	 UK),	 previously	 equilibrated	 with	 10	 column	 volumes	 (CV)	 of	purification	 buffer	 (20	 mM	 imidazole).	 Following	 loading	 of	 the	 sample,	 the	column	was	washed	with	5	CV	of	purification	buffer	(20	mM	imidazole)	and	LacY	was	 eluted	with	 50	CV	of	 elution	 buffer	 (75	mM	 im-idazole).	 The	 eluted	protein	was	 transferred	 directly	 to	 a	 gel	 filtration	 column	 (SUP200	 Superdex,	 GE	Healthcare)	 to	 remove	 imidazole	 as	 well	 as	 multimeric	 protein	 species.	 The	 re-sulting	 protein	 fractions	were	 analysed	 by	 SDS-PAGE	 using	NuPAGE	 4-12%	 gels	with	MES	Buffer	(Thermo	Fisher	Scien-tific)	and	UV-vis	spectroscopy	to	verify	the	purity	 of	 the	 protein	 samples	 and	 determine	 their	 concentrations,	 respectively.	The	LacY	concentration	in	the	supernatant	was	determined	from	the	absorbance	at	280	nm,	using	 εLacY	 =	76391	M-1	 cm-1.	After	purification,	 aliquoted	 samples	were	frozen	in	liquid	N2	and	stored	at	-80	°C	until	use.			
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LacY	Aggregation	Procedure	LacY	 in	 50	 mM	 sodium	 phosphate	 0.05%	 DDM	 pH	 7.4	 was	 used	 directly	 as	obtained	 from	 the	 purification	 (2,	 4	 and	 occasionally	 8	 μM	 samples)	 or	concentrated	(to	8,	16	or	32	μM),	and	aggregation	was	initiated	by	increasing	the	temperature	 of	 the	 sample	 to	 37	 °C.	 When	 concentrating	 of	 the	 protein	 was	required,	Vivaspin20	concentrators	with	a	100	kDa	cut-off	(Millipore,	Watford,	UK)	were	 used	 as	 these	 devices	 were	 reported	 to	 cause	 insignificant	 changes	 in	 the	DDM	 concentration	 (48,	 49).	 The	 final	 DDM	 concentration	 was	 determined	 via	colorimetric	 determination	 of	 the	 glycoside	 content	 (49).	 The	 samples	 were	continuously	kept	on	 ice	or	at	4	°C	to	minimize	aggregate	 formation	prior	to	any	measurement.	 Concentrating	 the	 samples	 took	 approximately	 35	 minutes	 from	defrosting.	 Samples	 were	 used	 immediately	 after	 concentrating,	 and	 were	 not	refrozen.		
ThT	Fluorescence	Assay	LacY	 (2,	4	and	8	μM	as	obtained	after	purification)	 in	50	mM	sodium	phosphate	0.05%	DDM	pH	7.4,	was	 incubated	at	37	°C	 in	 the	presence	of	4	μM	of	ultrapure	ThT	 (Sigma-Aldrich,	 Dorset,	 UK).	 The	 change	 in	 the	 ThT	 fluorescence	 intensity	(excitation	 at	 440	 nm,	 emission	 at	 480	 nm)	 was	 monitored	 over	 48	 h	 using	 a	FLUOstar	 Optima	 plate	 reader	 (BMG	 Labtech,	 Aylesbury,	 UK)	 under	 quiescent	conditions.	Corning	96-well	plates	with	half-area	(black/clear	bottom	polystyrene)	nonbinding	surfaces	(Fisher	Scientific,	Loughborough,	UK)	were	used.		
	
Analysis	of	LacY	in	the	Supernatant	At	the	end	of	an	aggregation	experiment,	the	samples	were	centrifuged	(15000	X	g,	15	min),	and	the	concentration	of	the	free	monomer	was	calculated	by	measuring	the	 UV-vis	 spectrum	 of	 the	 supernatant.	 The	 same	 samples	 were	 analysed	 with	SDS-PAGE.	 An	 aliquot	 of	 the	 LacY	 supernatant	 solution	 (15	 μL)	was	mixed	with	NuPAGE	 LDS	 sample	 buffer	 (ThermoFisher	 Scientific)	 and	 10	 μL	 of	 the	 solution	was	 run	 on	 a	 NuPAGE	 4-12%	 Bis-Tris	 gel	 (ThermoFisher	 Scientific).	 A	 tricolor	protein	marker	 (Stratech	 Scientific,	 Suffolk,	 UK)	was	 run	 in	 lane	 4.	 The	 gel	 was	stained	with	InstantBlue	(Expedeon,	Swavesey,	UK).	
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Circular	Dichroism	Spectroscopy	A	LacY	solution	(2	μM)	in	50	mM	phosphate	buffer,	0.05%	DDM,	pH	7.4,	before	and	after	 incubation	 at	 37	 °C	 for	 48	 h,	 was	 deposited	 in	 a	 circular	 cell.	 Far-UV	 CD	spectra	were	 recorded	on	 an	Aviv	Circular	Dichroism	Spectrophotometer,	Model	410	(Biomedical	Inc.,	Lakewood,	NJ,	USA),	with	specially	adapted	sample	detection	(the	 detector	 is	 placed	 closer	 to	 the	 sample)	 to	 minimize	 scattering	 artefacts.	Quartz	circular	cells	were	used,	and	CD	spectra	were	obtained	by	averaging	2	to	5	individual	spectra	recorded	between	260	nm	and	190	nm	at	0.5	nm	interval	with	an	 averaging	 time	 of	 2	 s.	 For	 each	 protein	 sample,	 the	 CD	 signal	 of	 the	 buffer	without	protein	was	recorded	and	subtracted	 from	the	CD	signal	of	each	protein	sample.	 The	 multiple	 scans	 were	 averaged	 and	 the	 buffer	 background	 was	subtracted.	 The	 data	 were	 then	 converted	 from	 millidegrees	 to	 mean	 residue	ellipticity(50).		
	
Fourier	Transform	Infrared	Spectroscopy	A	LacY	solution	(concentrated	to	16	μM)	in	50	mM	phosphate	buffer,	0.05%	DDM,	pH	7.4,	before	and	after	incubation	at	37	°C	for	48	h,	was	deposited	(10	μL)	into	a	BioATR	cell	(Bruker	Optics,	Coventry,	UK).	FT-IR	absorption	spectra	were	collected	in	 absorbance	 mode	 on	 an	 FT-IR	 Vertex	 70	 (Bruker)	 spectrometer	 fitted	 with	BioATR	cell	(Bruker	Optics,	Coventry,	UK).	Spectra	were	corrected	for	the	presence	of	 sodium	 phosphate	 50	mM,	 pH	 7.4,	 0.05%	DDM.	 The	 secondary	 derivative	 for	each	spectrum	was	calculated	using	OriginPRO.	In	order	to	reduce	the	noise	a	FFT	filter	 (10	 pt)	was	 initially	 applied,	 successively	 the	 curves	were	 normalised	 and	smoothed	by	a	Savitski-Golay	filter	(9	pt).	
	
Transmission	Electron	Microscopy	LacY	solutions	(concentrated	to	16	μM)	in	50	mM	phosphate	buffer,	0.05%	DDM,	pH	7.4,	were	incubated	at	37	°C	for	48	h	and	5	μL	of	sample	was	applied	to	carbon-coated	 400-mesh	 copper	 grids	 (EM	 Resolutions,	 Saffron	 Walden,	 UK).	 Samples	were	 stained	 with	 2%	 (w/v)	 uranyl	 acetate	 and	 imaged	 using	 a	 FEI	 Tecnai	 G2	transmission	 electron	 microscope	 (Multi-Imaging	 Unit	 in	 the	 Department	 of	Physiology,	Development	and	Neuroscience,	University	of	Cambridge,	UK).	Images	
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were	analysed	using	the	SIS	Megaview	II	Image	Capture	system	(Olympus).		
	
X-ray	Fibre	Diffraction	Pattern	Analysis	LacY	solutions	(concentrated	to	16	and	32	μM)	in	50	mM	phosphate	buffer,	0.05%	DDM,	pH	7.4,	were	 incubated	at	37	 °C	 for	48	h.	The	samples	 for	 fibre	diffraction	were	dialysed	against	sodium	phosphate	50	mM,	pH	7.4,	0.05%	DDM	and	a	5	μL	aliquot	was	 pipetted	 between	wax	 stalks	 and	 left	 to	 dry.	 The	 experiments	were	performed	 at	 the	 Crystallographic	 X-ray	 Facility,	 Department	 of	 Biochemistry,	University	of	Cambridge,	UK.	X-rays	with	a	wavelength	of	1.5418	Å	were	produced	by	a	rotating	copper	anode	MISCROSTAR	generator	(Bruker-AXS,	Ltd),	collimated	and	 focused	by	HELIOS-MX	high-brightness	multilayer	X-ray	optics.	 Images	were	acquired	 on	 a	 PLATINUM135	 CCD	 area	 detector	 (Bruker-AXS,	 Ltd	 Rigaku-MSC).	The	exposure	time	for	the	diffraction	images	was	60	s	in	each	case.		The	diffraction	pattern	viewing	and	analysis	was	carried	out	using	PORTEUM2	software	package	(reference:	PROTEUM	2	User	Manual,	Bruker	AXS,	2010).			
Results	and	Discussion		
LacY	has	a	high	intrinsic	propensity	for	aggregation	In	 a	 preliminary	 assessment,	 we	 used	 the	 CamSol	 method(46)	 to	 calculate	 the	sequence-dependent	solubility	of	LacY	(Figure	1),	which	is	inversely	related	to	the	aggregation	 propensity	 score	 (see	Material	 and	Methods).	 As	 the	 native	 state	 of	LacY	 comprises	 12	 transmembrane	 α-helices,	 the	 sequence	 may	 be	 expected	 to	include	highly	hydrophobic	and	aggregation-prone	regions	outside	its	natural	lipid	environment,	 which	 are	 indeed	 present	 (red	 regions	 in	 the	 sequence	 profile	 in	
Figure	1).		
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protein	in	solution(52).	In	addition,	it	was	established	that	LacY	is	stabilized	by	low	temperature	 and	 glycerol(52),	 which	 was	 added	 in	 all	 purification	 buffers	 (in	Materials	 and	 Methods).	 Despite	 these	 considerations,	 purification	 of	 LacY	 is	challenging	 as	 the	 protein	 tends	 to	 aggregate	 readily	 at	 room	 temperature	 and	even	 when	 kept	 on	 ice	 for	 few	 hours.	 Furthermore,	 as	 several	 biophysical	techniques	utilised	in	our	studies	require	higher	protein	concentrations	(at	least	in	the	 range	 of	 15-30	 μM)	 than	 those	 initially	 obtained	 from	 the	 purification	(typically	 in	 the	 range	 of	 2-6	 μM),	 the	 samples	 often	 required	 concentrating,	thereby	placing	the	protein	under	conditions	where	it	is	particularly	vulnerable	to	aggregation	prior	to	the	start	of	any	experiment.	This	aspect	of	the	system	made	it	difficult	to	characterise	the	precise	starting	point	of	the	aggregation	reaction,	and	consistently	to	avoid	the	presence	of	a	small	fraction	of	aggregated	species	at	the	initiation	of	the	experiments.	
 In	 the	 experimental	 protocol	 described	here,	 LacY	 (in	50	mM	sodium	phosphate	pH	7.4,	0.05%	DDM)	was	used	as	obtained	 from	the	purification	procedure	 (2,	4	and	 8	 μM	 samples)	 or	 concentrated	 to	 8,	 16	 or	 32	 μM.	 Amyloid-like	 structures	often	 are	 observed	 under	 conditions	 that	 destabilize	 the	 protein	 under	 study(7),	and	 as	 temperature	 increase	 in	 particular	 is	 know	 to	 destabilize	 LacY(52),	aggregation	 of	 the	 protein	 was	 initiated	 by	 increasing	 the	 temperature	 of	 the	sample	from	4	°C	to	37	°C.	Visible	precipitation	of	LacY	in	the	micellar	environment	was	observed	after	approximately	4	h	for	the	16	μM	samples	to	approximately	8	h	for	 the	 2	 μM	 samples,	 with	 increasing	 turbidity	 of	 the	 solutions	 at	 longer	incubation	times	of	up	to	48	h.	Aliquots	taken	at	different	time	points	during	the	incubation	were	centrifuged	and	the	supernatant	at	each	time	point	was	analysed.	The	concentration	of	LacY	in	the	supernatant	at	each	time	point	was	obtained	from	UV-vis	spectra	at	280	nm	(Table	1)	and	observed	to	decrease	gradually	over	time,	resulting	in	less	than	20%	of	the	initial	protein	remaining	in	solution	after	48	h	of	incubation.	This	 ratio	 is	 consistent	 for	 the	samples	at	higher	concentrations.	The	same	 samples	were	analysed	by	SDS-PAGE	 (Figure	 2)	 and	 the	 increasingly	 faint	bands	 observed	 for	 the	 samples	 after	 increasing	 incubation	 times	 confirm	 the	nearly	complete	conversion	of	the	monomer	into	precipitating	species	after	48	h.	
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Table	 1.	 LacY	 concentration	 in	 the	 supernatant	 over	 time.	LacY	solutions	(2	μM)	incubated	in	50	mM	phosphate	buffer	pH	7.4	with	0.05%	DDM	(37	°C,	48	h),	were	centrifuged	after	0,	2,	4,	6,	24	and	48	h	to	precipitate	the	aggregated	fraction,	and	the	UV-vis	signal	at	280	nm	of	the	remaining	supernatant	was	monitored.	The	LacY	concentration	in	the	supernatant	was	determined	from	the	absorbance	at	280	nm,	using	εLacY	=	76391	M-1	cm-1.	An	average	of	two	measurements	from	separate	samples	is	shown	(SD	+/-	0.005	for	A280).		 Time	(h)	 A280	 c	(μM)	0	 0.148	 1.94	2	 0.128	 1.68	4	 0.089	 1.15	6	 0.085	 1.11	24	 0.052	 0.68	48	 0.031	 0.40		In	 the	 following	 sections,	we	describe	 a	 range	 of	 biophysical	 techniques	 that	we	have	 used	 to	 define	 the	 structural	 nature	 of	 the	 observed	 aggregates	 and	 to	characterise	 their	 properties.	 Since	 near-complete	 precipitation	 of	 LacY	 from	solution	was	observed	after	48	h	we	did	not	extend	experiments	beyond	this	initial	time	frame.					
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Figure	2.	Fraction	of	LacY	in	the	supernatant	over	time.	LacY	solutions	(2	μM)	incubated	in	50	mM	phosphate	buffer	pH	7.4	with	0.05%	DDM	(37	°C,	48	h),	were	centrifuged	to	precipitate	 the	aggregated	 fraction	and	the	remaining	supernatant	was	 analysed	 by	 SDS-PAGE	 gel	 after	 0,	 1,	 2,	 3,	 4,	 5,	 6,	 7,	 8,	 24	 and	 48	 h	 (as	indicated).	LacY	appears	at	~28	kDa	since	it	does	not	unfold	in	SDS	and	thus	runs	in	 its	 folded	 state	 (its	 expected	 MW	 is	 48	 kDa).	 The	 experiment	 was	 repeated	twice;	a	representative	data	set	is	shown.		
LacY	aggregates	are	ThT	positive	Amyloid-specific	 fluorescent	 dyes	 have	 been	 used	 for	 many	 years	 to	 identify	amyloid	 assemblies(1)	 and	 in	 vitro	 assays	 involving	 these	 compounds	 remain	 a	powerful	 approach	 to	 characterising	 amyloid-like	 fibrils	 and	 to	 monitoring	 the	kinetics	of	 their	 formation.	One	of	 the	most	widely	used	dyes	 is	ThT,	a	positively	charged	 benzothiazole	 salt	 that	 shows	 increased	 fluorescence	 upon	 interaction	with	amyloid	fibrils(53).	Membrane	proteins	are	highly	hydrophobic	in	nature	and	could	 therefore	 adopt	 a	 different	 binding	 mode	 to	 ThT	 from	 cytosolic	 proteins.	Although	some	studies	have	suggested	that	ThT	binding	to	amyloid	fibrils	involves	the	formation	of	ThT	micelles	as	a	result	of	hydrophobic	interactions(54),	a	model	in	which	 ThT	 specifically	 interacts	 with	 the	 cross-β	 strands	 that	 characterise	 the	unique	amyloid	architecture	is	more	widely	accepted(53).			LacY	solutions	with	concentrations	of	2,	4	and	8	μM	were	incubated	at	37	°C	in	the	presence	of	4	μM	ThT,	and	the	fluorescence	signal	was	monitored	over	the	course	of	48	h.	Within	minutes,	an	 increase	 in	 the	 fluorescence	 intensity	at	480	nm	was	
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observed,	and	sigmoidal	aggregation	curves	were	obtained	by	plotting	the	relative	fluorescence	 intensities	 as	 a	 function	 of	 time	 (Figure	 3).	 The	 initial	 high	intensities,	 which	 were	 seen	 in	 all	 samples,	 are	 often	 observed	 in	 this	 type	 of	kinetic	 experiments,	 and	 can	 be	 attributed	 to	 an	 equilibration	 at	 the	 higher	temperature	(from	4	°C	to	37	°C	in	this	case).	Normalisation	of	the	data	shows	an	increase	in	the	aggregation	rate	with	increasing	initial	protein	concentration	(up	to	8	μM	–	as	these	samples	could	be	obtained	directly	after	purification	without	the	need	 for	 concentration)	 (Figure	 3B).	 The	 ThT-positive	 character	 of	 the	 LacY	aggregates	provides	a	 first	 indication	 that	 they	may	have	a	β-sheet	rich	amyloid-like	nature.	The	enhanced	fluorescence	of	ThT	inside	micelles,	however,	could	be	a	result	 of	 electrostatic	 interactions	 with	 the	 charged	 detergent	 molecules(55).	Indeed,	 significant	 effects	 of	 this	 type	have	been	observed	 for	ThT	 simply	 in	 the	presence	 of	 the	 anionic	 surfactant,	 sodium	 dodecyl	 sulphate	 (SDS),	 whereas	relatively	 insignificant	 intensity	 changes	 were	 observed	with	 neutral	 detergents	such	as	Tween	20	and	Triton-X-100(55).	Since	DDM	belongs	to	the	latter	category	of	detergents,	only	minor	intensity	changes	were	expected,	and	none	were	observed,	in	its	presence	(Figure	S1).	All	spectra	were	corrected	for	potential	buffer	effects	by	monitoring	the	ThT	fluorescence	in	sodium	phosphate	buffer	containing	equal	DDM	concentrations	to	those	of	the	sample	under	investigation,	showing	that	the	increase	 in	 ThT	 fluorescence	 correlates	with	 the	 presence	 of	 LacY	 aggregates	 as	determined	by	centrifugation.	
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Figure	 3.	 Enhancement	 of	 ThT	 fluorescence	 by	 LacY	 aggregates.	 (A)	 ThT	fluorescence	changes	in	monomer	solutions	of	2	μM	(yellow),	4	μM	(red)	and	8	μM	(blue)	LacY	 (in	duplicate)	 in	50	mM	sodium	phosphate	pH	7.4	with	0.05%	DDM.	The	solutions	were	 incubated	(37	°C,	48	h)	 in	 the	presence	of	4	μM	ThT	and	the	ThT	 fluorescence	 was	 continuously	 monitored.	 The	 fluorescence	 spectra	 were	corrected	for	the	signal	in	50	mM	sodium	phosphate	pH	7.4	with	0.05%	DDM.	(B)	The	 spectra	 in	 panel	 (A)	 were	 normalised	 by	 subtracting	 the	 minimum,	 and	dividing	by	 the	maximum	 fluorescence	 intensity	 for	 the	 respective	data	 set.	This	procedure	 enables	 a	 straightforward	 comparison	 of	 the	 slopes	 of	 the	 intensity	profiles	 for	 different	 concentrations.	 The	 experiment	 was	 repeated	 5	 times;	 a	representative	data	set	is	presented.		
LacY	converts	from	α-helical	to	parallel	β-sheet	structure	In	 addition	 to	 monitoring	 dye-binding	 properties,	 direct	 detection	 of	 their	characteristic	 β-sheet	 architecture	 is	 a	 key	 parameter	 in	 the	 identification	 of	amyloid-like	 fibrils.	 Circular	 dichroism	 (CD)	 and	 Fourier	 transform	 infrared	(FT/IR)	 spectroscopies	 are	 powerful	 techniques	 used	 to	 characterise	 protein	secondary	 structure	 content	 and	were	 used	 to	monitor	 the	 changes	 in	 the	 LacY	secondary	 structure	 upon	 aggregation(56).	 The	 native	 LacY	 monomer	 has	 been	studied	extensively;	an	α-helical	structure	content	of	about	85%	has	been	reported	from	CD	measurements	and	is	consistent	with	the	crystal	structure(57).		Aliquots	 from	a	LacY	 solution	at	 a	 concentration	of	2	μM	were	 taken	before	and	after	 incubation	at	37	 °C	 for	48	h,	 respectively,	 and	CD	spectra	were	recorded	of	
A B
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each	 sample	 (Figure	 4).	The	 spectrum	of	LacY	as	obtained	 from	 the	purification	and	 before	 incubation	 possesses	 characteristic	 minima	 at	 208	 and	 223	 nm,	indicative	of	a	highly	α-helical	structure,	in	accord	with	the	LacY	native	fold(57).	The	signal	 intensity	was	reduced	significantly	after	 incubation	of	the	sample	at	37	°C,	indicating	a	loss	of	soluble	protein.	This	result	indicates	that	only	soluble	protein	is	being	detected,	while	the	aggregated	fraction	crashes	out	of	solution	and	does	not	result	in	a	detectable	signal.	Further	secondary	structure	determination	therefore	was	performed	using	FT/IR	spectroscopy.	This	technique	furthermore	has	a	higher	sensitivity	 and	 accuracy	 for	 resolving	 β-sheet	 compositions(58-60).	 For	 example,	whereas	only	changes	in	α-helical	content	were	detectable	by	CD	spectroscopy	in	the	study	of	the	secondary	structure	changes	of	opsin	variants,	changes	in	both	α-helical	 and	 β-sheet	 content	 were	 observed	 for	 the	 same	 system	 using	 FT/IR	spectroscopy(28).	 As	 FT/IR	 requires	 higher	 protein	 concentrations	 than	 those	obtained	from	the	purification	procedure,	a	concentrated	sample	was	used	for	this	analysis.	 The	 DDM	 concentration	 of	 the	 concentrated	 samples	 was	 verified	 via	colorimetric	 determination	 of	 the	 glycoside	 content(49)	 and	 only	 small	 increases	(from	 0.050	 to	 up	 to	 0.057%	Table	 S1)	 were	 detected.	 Aliquots	 from	 the	 LacY	solution	at	a	concentration	of	16	μM	were	taken	before	and	after	incubation	at	37	°C	for	48	h,	respectively,	and	FT/IR	spectra	were	recorded	of	each	sample	(Figure	
5A).	The	amide	I	/	II	regions	of	the	spectra	at	both	time	points	are	shown,	as	well	as	the	second	derivative	spectra	(Figure	5B).					
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Figure	 4.	 CD	 intensity	 decrease	 upon	 aggregation	 of	 LacY.	 LacY	 (2	 μM)	was	incubated	in	50	mM	phosphate	buffer	pH	7.4	with	0.05%	DDM,	at	37	°C.	CD	spectra	were	recorded	before	(blue)	and	after	48	h	of	incubation	(red).	The	spectra	were	corrected	for	50	mM	sodium	phosphate	pH	7.4	with	0.05%	DDM.	A	minimum	of	3	scans	 was	 averaged	 per	 time	 point.	 The	 experiment	 was	 repeated	 twice;	 a	representative	data	set	is	presented.			The	amide	I	band	obtained	for	the	LacY	sample	before	incubation	has	its	maximum	at	1653	cm-1,	which	is	the	characteristic	region	for	α-helical/disordered	structure	content(61,	 62).	 This	 pre-incubation	 sample,	 although	 predominantly	 α-helical	 in	nature,	may	contain	some	aggregated	species	due	to	its	high	protein	concentration.	After	 48	 h,	 the	main	 peak	 is	 shifted	 to	 1623	 cm-1	where	 intermolecular	 β-sheet	structure	 has	 its	 characteristic	 maximum(61).	 The	 differences	 between	 β-sheet	structure	 in	 amyloid-like	 fibrils	 compared	 to	 native	 states	 of	 proteins	 is	 evident	from	 FT/IR	 data,	 with	 amyloid-like	 fibrils	 specifically	 populating	 the	 amide	 I	region	 between	 1610	 and	 1630	 cm-1(63).	 A	 shift	 of	 the	 amide	 II	 band	 to	 lower	wavelengths	further	reflects	the	formation	of	intermolecular	hydrogen	bonds	upon	incubation	 of	 the	 sample	 at	 37	 °C	 for	 48	 h.	 Deconvolution	 of	 the	 FT/IR	 data	 in	
Figure	5A	indicates	the	conversion	of	mainly	α-helical	structure	to	35%	parallel	β-sheet	 conformation	 after	 incubation	 at	 37	 °C	 for	 48	 h.	 In	 addition,	 the	 β-turn	conformation	 (1682	 cm-1)	 and	 antiparallel	 β-sheet	 (1695	 cm-1)	 contents	 slightly	increase	upon	 incubation	of	 the	sample	and	 these	changes	are	 intimately	related	with	formation	of	cross-β	sheet	structure(63).	The	FT/IR	data	thus	indicate	that	the	nature	of	the	β-sheet	fraction	is	typical	of	amyloid-like	fibrils(63).	
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high	 concentrations	 of	 denaturant	 than	 disordered	 aggregates(64).	 We	 therefore	incubated	the	aggregates	in	urea	(8	M)	or	guanidinium	hydrochloride	(3	M)	for	1	h,	centrifuged	 the	 remaining	 insoluble	 material	 and	 re-examined	 it	 by	 TEM.	 The	samples	prepared	in	this	manner	show	clearly	the	presence	of	substantially	more	homogeneous	 structures	 (Figure	 6D),	 indicating	 that	 a	 denaturant-resistant	fibrillar	fraction	can	be	isolated.	Following	treatment	of	the	samples	in	urea	(8	M)	or	guanidinium	hydrochloride	(3	M),	the	diffraction	pattern	was	seen	to	be	much	more	 highly	 resolved	 as	 well	 (Figure	 6B),	 showing	 reflections	 at	 4.6	 Å,	characteristic	 of	 inter-strand	 spacing	 and	 at	 10.8	 Å,	 corresponding	 to	 the	 inter-sheet	spacing	as	observed	in	amyloid	fibrils(2).	The	combination	of	these	reflections	is	 consistent	 with	 the	 cross-β	 pattern	 indicative	 of	 a	 β-sheet	 core	 structure,	 in	which	 the	 constituent	 β-strands	 lie	 at	 right	 angles	 to	 the	 axis	 of	 the	 fibril.	 The	characterised	 inter-strand	 and	 inter-sheet	 spacing,	 in	 combination	 with	 an	extended	 degree	 of	 β-sheet	 content,	 enhanced	 ThT	 fluorescence	 emission	 and	evidence	 for	 a	 fibrillar	 morphology	 indicate	 the	 ability	 of	 LacY	 to	 convert	 into	amyloid-like	fibrils	in	vitro.				
Conclusions		The	 generality	 of	 the	 amyloid	 phenomenon	 has	 been	 firmly	 established	 for	cytosolic	 proteins	 through	 a	 large	 number	 of	 case	 studies(1-8,	10).	 By	 contrast,	 the	extent	of	this	phenomenon	remains	still	rather	unclear	for	membrane	proteins,	for	which	 the	 conversion	 into	 β-sheet	 rich	 aggregates	 has	 been	 previously	suggested(16,	23,	28,	31,	32),	but	only	preliminary	evidence	for	fibril	formation	so	far	has	been	provided(16,	23,	32).	In	this	work	we	have	reported	an	extensive	characterisation	of	the	aggregates	of	LacY	as	amyloid-like	fibrils.	As	many	membrane	proteins	have	sequences	 and	 overall	 architectures	 similar	 in	 nature	 to	 those	 of	 LacY,	 we	anticipate	that	amyloid-like	structures	will	be	described	in	detail	for	a	wider	range	of	 membrane	 proteins,	 and	 under	 a	 variety	 of	 conditions,	 thus	 enabling	 the	biological	relevance	of	these	aggregates	to	be	progressively	defined.		
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Supporting	Information	Table	 S1	 indicating	 the	DDM	 concentration	 of	 LacY	 samples	 after	 concentrating,	and	 Figure	 S1	 showing	 ThT	 intensity	 profiles	 for	 the	 DDM	 containing	 buffer	 in	absence	of	the	protein,	are	presented	in	the	Supporting	Information.		
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